A Comparative Clinical Effectiveness Trial of Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab to Prevent Relapses in Neuromyelitis Optica Spectrum Disorder (NMOSD)

Serum Proteomics Reveals Altered Pathways in Double-negative Neuromyelitis Optica Spectrum Disorder

The Role of SATB1 and the Treg/Th17 Cell Balance in Neuromyelitis Optica Spectrum Disorders

Author:Shen, Ang   Li, Hui   Liu, Hongbo   

Session Name:P3: Autoimmune Neurology: NMOSD/MOGAD 3  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P3.004  

Author Institution:

Seasonality of Initial Attack Onset in AQP4+ NMOSD, MOGAD, and MS: Observations from a US-based Multicenter Cohort